1.3 California Security Prescription Forms & E-Prescribing Mandates (B&P § 688)

California Security Prescription Forms & E-Prescribing Mandates

To combat the opioid epidemic and reduce prescription fraud, California has implemented strict regulations regarding how prescriptions—particularly those for controlled substances—must be generated, transmitted, and received.

California Security Prescription Forms

When a prescriber issues a paper prescription for any controlled substance (Schedule II, III, IV, or V), it must be written on a state-approved California Security Prescription Form. These forms are printed by Department of Justice (DOJ)-approved vendors and contain multiple security features designed to thwart counterfeiting, erasing, or altering.

Mandated Security Features

Pharmacists must be adept at visually inspecting security blanks for the following required features:

1. Void Pantograph: A latent, repetitive "VOID" pattern is printed across the entire front of the prescription blank. If the prescription is scanned or photocopied, the word "VOID" will prominently appear on the copy.
2. Chemical Void Protection: The paper is treated so that if chemical solvents (like bleach or acetone, used by forgers to "wash" ink off a stolen prescription) are applied, a stain or the word "VOID" will permanently appear.
3. Watermark: A watermark reading "California Security Prescription" is printed on the back of the blank. It is invisible when viewed directly but becomes clearly visible when held up to an angled light source.
4. Thermochromic Ink Feature: The prescription must contain a feature (often a red shield or a specific box) printed in thermochromic ink. This ink fades or changes color when exposed to heat (such as rubbing it with a thumb or breathing heavily on it) and returns to its original color when it cools.
5. Opaque Writing: An area of opaque writing so that the prescription cannot be easily erased and overwritten.
6. Check Boxes: Pre-printed check boxes indicating the quantity (e.g., 1-24, 25-49, 50-74, 75-100, 151 and over) so the prescriber can check off the amount, preventing a patient from easily adding a zero to change "10" to "100".
7. Six Quantity Check-Off Boxes: Specific to the quantity of the drug.
8. Refill Check Boxes: Check boxes indicating the number of refills authorized (or "Zero" if none).
9. Statement: The statement "Prescription is void if the number of drugs prescribed is not noted" must be printed on the bottom.
10. Preprinted Prescriber Information: The name, category of licensure, license number, federal controlled substance registration number (DEA number) of the prescribing practitioner.

The 11159.2 Exemption (Terminally Ill)

Under Health and Safety Code § 11159.2, prescriptions for Schedule II-V controlled substances for a patient suffering from a terminal illness do not require a California Security Prescription Form. They may be written on a standard prescription blank provided the prescriber writes or types "11159.2 exemption" on the prescription. A terminal illness is defined as an incurable and irreversible condition that will, in the opinion of the prescriber, result in death within one year.

Universal E-Prescribing Mandate (B&P Code § 688)

To further modernize the healthcare system and reduce medication errors resulting from illegible handwriting or stolen prescription pads, California enacted B&P Code § 688.

The Mandate

Effective January 1, 2022, all prescriptions in California—including non-controlled substances and Schedule II-V controlled substances—must be transmitted electronically as an e-prescription. Written, oral, and faxed prescriptions are no longer the standard method of transmission.

Exceptions to E-Prescribing

The law recognizes that technology is not infallible and that emergencies occur. Therefore, several exceptions permit a prescriber to issue a paper, oral, or faxed prescription. Key exceptions include:

• Technological or Electrical Failure: A temporary outage of the prescriber's electronic prescribing system, internet connection, or local power grid.
• Emergency Situations: Where a delay caused by attempting to e-prescribe would adversely impact the patient's medical condition.
• Prescription Cannot Be Sent Electronically: Certain complex prescriptions (e.g., compounded medications with complicated instructions, investigational drugs) may not fit into the standardized NCPDP fields of an e-prescribing platform.
• Out of State: The prescriber is located outside of California.
• Veterinary Prescriptions: Veterinarians are exempt from the e-prescribing mandate.

Pharmacist Responsibility under § 688

A critical aspect of B&P § 688 is the limitation on pharmacist burden. Pharmacists are NOT required to verify that an exception applies before dispensing a non-electronic prescription.

If a patient presents a valid paper prescription (on a security blank if controlled, or regular blank if non-controlled), the pharmacist can legally fill it. The pharmacist does not need to interrogate the prescriber or the patient to confirm there was a power outage or an emergency. The burden of compliance with the e-prescribing mandate lies with the prescriber, who must document the reason for the exception in the patient's medical record.

By understanding these security features and electronic mandates, pharmacists act as the final checkpoint in ensuring that prescription drugs are dispensed safely and legally.\n\n## The Role of CURES in Prescription Validation\n\nThe Controlled Substance Utilization Review and Evaluation System (CURES) is California's Prescription Drug Monitoring Program (PDMP). Pharmacists are legally mandated to consult CURES before dispensing a Schedule II-IV controlled substance to a patient for the first time, and periodically thereafter (typically at least once every six months for chronic therapy). CURES provides a comprehensive history of the patient's controlled substance prescriptions filled within the state, allowing pharmacists to identify potential "doctor shopping," polypharmacy, and high-risk medication combinations, such as concurrent opioid and benzodiazepine use. Effective utilization of CURES is not merely a statutory obligation but a critical clinical tool in fulfilling the pharmacist's corresponding responsibility. If a review of CURES reveals anomalous or concerning patterns, the pharmacist must exercise professional judgment, which may involve contacting the prescriber to verify the clinical rationale, discussing the findings directly with the patient, or ultimately refusing to dispense the medication if legitimate medical purpose cannot be confirmed. The meticulous integration of CURES data into the dispensing workflow is indispensable in the ongoing effort to mitigate prescription drug abuse and ensure patient safety.